Systemic lupus erythematosus scleritis
Systemic lupus erythematosus scleritis (SLE) is an autoimmune disease characterized by the production of anti-cell antibodies, cytoplasms, and cell membrane antigen antibodies. Systemic lupus erythematosus is more common in young women. The ratio of male to female is at least 1: 7 to 1: 9, and the age of onset is mostly 15 to 45 years, but it is also found in children and the elderly. The incidence of SLE in the black population in the United States is approximately three times that of the white population. The incidence of SLE in the general population is 15.5 / 100,000 to 50 / 100,000. The prevalence in China is higher than that in Western China, about 70 / 100,000 population, and the prevalence is also high among Chinese populations in the United States, Singapore and other places, which may be related to genetic factors. The prevalence of different regions and ethnic groups in China also varies. The epidemiological data of systemic lupus erythematosus scleritis is unknown.
The material in this site is intended to be of general informational use and is not intended to constitute medical advice, probable diagnosis, or recommended treatments.